This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Ajinomoto Co., Ltd.. Active years: 2010-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2012
Title: The Innovations of Hideyuki Yamaguchi
Introduction
Hideyuki Yamaguchi is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of integrin inhibitors. With a total of two patents to his name, Yamaguchi's work is recognized for its potential impact on medical treatments.
Latest Patents
Yamaguchi's latest patents include the crystals of isopropyl ester of N-(2,6-dichlorobenzoyl)-4-[6-(methylamino)methyl-1-methyl-2,4-dioxo-1,4-dihydroquinazoline-3(2H)-yl]-L-phenylalanine hydrochloride. These crystals are noted for their utility as α4 integrin inhibitors. The production method and applications of these crystals highlight their importance in therapeutic contexts.
Career Highlights
Yamaguchi is currently employed at Ajinomoto Co., Ltd., a leading company in the food and pharmaceutical industries. His work at Ajinomoto has allowed him to focus on innovative solutions that address complex health issues. His contributions have been instrumental in advancing the company's research initiatives.
Collaborations
Yamaguchi has collaborated with esteemed colleagues such as Koichi Fujita and Shinichiro Takahashi. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Hideyuki Yamaguchi's innovative work in the field of pharmaceuticals exemplifies the impact of dedicated research and collaboration. His patents reflect a commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile